Joon Lee
Stock Analyst at Truist Financial
Total Price Targets
25
Stocks Covered
13
Sectors
Healthcare
Most Recent
Mar 10, 2026
Notable Calls (Last 12 Months)
Most Bullish
Stocks Covered by Joon Lee
| Symbol | Company | Latest Target | Current Price | Upside | # Targets | Last Updated |
|---|---|---|---|---|---|---|
| VRTX | Vertex Pharmaceuticals Incorporated | $525.00 | $425.06 | +23.5% | 2 | Mar 10, 2026 |
| AXSM | Axsome Therapeutics, Inc. | $200.00 | $204.09 | -2.0% | 4 | Feb 23, 2026 |
| BMRN | BioMarin Pharmaceutical Inc. | $100.00 | $54.20 | +84.5% | 3 | Dec 23, 2025 |
| ANAB | AnaptysBio, Inc. | $36.00 | $66.67 | -46.0% | 2 | Nov 10, 2025 |
| RAPP | Rapport Therapeutics, Inc. Common Stock | $44.00 | $34.13 | +28.9% | 1 | Sep 16, 2025 |
| JAZZ | Jazz Pharmaceuticals plc | $205.00 | $202.38 | +1.3% | 1 | Aug 28, 2025 |
| CORT | Corcept Therapeutics Incorporated | $135.00 | $51.08 | +164.3% | 3 | May 6, 2025 |
| VKTX | Viking Therapeutics, Inc. | $75.00 | $29.80 | +151.7% | 2 | Apr 28, 2025 |
| PRAX | Praxis Precision Medicines, Inc. | $75.38 | $330.59 | -77.2% | 1 | Sep 3, 2024 |
| CRSP | CRISPR Therapeutics AG | $100.00 | $51.72 | +93.4% | 1 | Aug 12, 2024 |
| EDIT | Editas Medicine, Inc. | $12.00 | $2.91 | +312.4% | 3 | Aug 8, 2024 |
| VYGR | Voyager Therapeutics, Inc. | $18.00 | $3.75 | +379.4% | 1 | May 10, 2023 |
| NTLA | Intellia Therapeutics, Inc. | $160.00 | $13.20 | +1112.1% | 1 | Feb 15, 2022 |
Recent Activity
- Mar 10, 2026— Set$525.00price target onVRTX(Vertex Pharmaceuticals Incorporated)
- Feb 23, 2026— Set$200.00price target onAXSM(Axsome Therapeutics, Inc.)
- Dec 23, 2025— Set$100.00price target onBMRN(BioMarin Pharmaceutical Inc.)
- Nov 10, 2025— Set$36.00price target onANAB(AnaptysBio, Inc.)
- Oct 28, 2025— Set$80.00price target onBMRN(BioMarin Pharmaceutical Inc.)
- Sep 16, 2025— Set$44.00price target onRAPP(Rapport Therapeutics, Inc. Common Stock)
- Aug 28, 2025— Set$205.00price target onJAZZ(Jazz Pharmaceuticals plc)
- May 6, 2025— Set$135.00price target onCORT(Corcept Therapeutics Incorporated)
- Apr 28, 2025— Set$75.00price target onVKTX(Viking Therapeutics, Inc.)
- Feb 3, 2025— Set$190.00price target onAXSM(Axsome Therapeutics, Inc.)
- Sep 30, 2024— Set$76.00price target onCORT(Corcept Therapeutics Incorporated)
- Sep 17, 2024— Set$90.00price target onBMRN(BioMarin Pharmaceutical Inc.)
- Sep 3, 2024— Set$75.38price target onPRAX(Praxis Precision Medicines, Inc.)
- Aug 15, 2024— Set$30.00price target onANAB(AnaptysBio, Inc.)
- Aug 12, 2024— Set$100.00price target onCRSP(CRISPR Therapeutics AG)
- Aug 8, 2024— Set$12.00price target onEDIT(Editas Medicine, Inc.)
- Aug 5, 2024— Set$550.00price target onVRTX(Vertex Pharmaceuticals Incorporated)
- Jun 4, 2024— Set$65.00price target onCORT(Corcept Therapeutics Incorporated)
- May 16, 2024— Set$120.00price target onVKTX(Viking Therapeutics, Inc.)
- May 10, 2023— Set$18.00price target onVYGR(Voyager Therapeutics, Inc.)
Frequently Asked Questions
Who is Joon Lee?
Joon Lee is a stock analyst at Truist Financial covering 13 stocks primarily in Healthcare. They have issued 25 price targets since Sep 29, 2021.
What stocks does Joon Lee cover?
Joon Lee currently covers 13 stocks, including AXSM, BMRN, CORT, EDIT, VRTX.
What is Joon Lee's latest price target?
Joon Lee's most recent price target was $525.00 on VRTX (Vertex Pharmaceuticals Incorporated), set on Mar 10, 2026.
What is Joon Lee's highest price target?
Joon Lee's highest issued price target is $550.00 on VRTX, set on Aug 5, 2024.
More Analysts at Truist Financial
Coverage based on publicly published price targets. Not investment advice.